27 Oct 2022

CDMO: Health is a Joint Project

Indena’s view and technology expansion to support partners’ developments.

Supported by more than 100 year experience, Indena has been involved ever since in the CDMO activities on behalf of its partners, even before CDMO was so named. Starting from the extraction, chromatographic purification and isolation of natural derivatives, a core expertise of the company since its foundation, a significant technological expansion has been carried out over the years, thus now mastering fermentation (including toxic compounds), synthesis of potent and highly potent APIs and spray drying of difficult molecules.

Several technological solutions will be presented, highlighting cases where a combination of different techniques available have been instrumental to successful product development.

Did you enjoy this session? If so, you might like to visit our Connect to Frankfurt platform, where you can browse our collection of 30+ on-demand webinars and learn about our upcoming CPHI Frankfurt event, taking place 1-3 November in Frankfurt, Germany.

Bringing together the global supply chain under one roof, CPHI Frankfurt puts you at the heart of pharma. Can’t attend in person? You can access many of the event offerings online! Browse our exhibitor list, arrange meetings, view on-site content and network – all from home.

Content provided by our supplier

Indena SpA

  • IT
  • 2015
    On CPHI since
  • 5
  • 500 - 999
Company types
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis

Other Content from Indena SpA (9)

  • Whitepaper CDMO services

    We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.
  • Whitepaper Spray Drying services

    Indena offers SD services from organic solvents (also in the presence of excipients). Equipped with two industrial SDs, the company is further investing in a smaller equipment dedicated to HIPOs.
  • Whitepaper Indena CDMO technology overview

    This presentation covers the full Indena technological offer for CDMO services.

    This whitepaper gives an overview on the HPAPIs market, the technological challenges they pose and the approach Indena has adopted.
  • Video Indena at CPHI WorldWide 2017

    Have a look at the interview with Indena and their BD & Licensing Director, Stefano Togni. In the interview she talks about, among other things, their facilities around the world and what updates they have to offer.
  • Video Cannabinoids Status Quo

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. The session explores: Exploring the Medical Cannabis Opportunity for Pharma CBD as an API: What lies ahead Cannabis product development and design strategies Overview of the international cannabis product landscape Key considerations when incorporating pharmaceutical technologies Current and future areas of exploration Case Study: Medicinal Cannabis in The Netherlands - Status Quo
  • Video Indena and its offering at a glance

    In this video Stefano Togni, BD Director-CDMO, will highlight Indena latest technologies and offering in the CDMO area.
  • Video Indena CPHI video interview 2019 - new implemented technologies

    In this video, Indena's representative highlights the latest technological implementation and the ongoing technological expansion. It is covering the area of HPAPIs, Spray Drying from organic solvents, pilot pharmaceutical production of APIs and fermentation of toxic compounds.
  • Video Indena at CPHI Worldwide 2018

    Mr. Stefano Togni, BD & Licensing Director, Indena S.p.A. speaks with CPHI TV at CPHI Worldwide in Madrid